McAdam LLC’s Organon & Co OGN Stock Holding History

McAdam LLC’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12,413	Closed	-$89K	–	462
2025 Q4	$89K	Buy	+12,413	New	+$98.1K	﹤0.01%	413

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

KBG

Kahn Brothers Group New York $633M AUM 39.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

McAdam LLC's OGN Position: Q1 2026 in Review

McAdam LLC sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 12,413 shares — an estimated $89K sold.

McAdam LLC first reported a position in OGN in Q4 2025 and held it in 1 quarter. The position peaked at $89K in Q4 2025. 609 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

McAdam LLC reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
McAdam LLC sold 12,413 Organon & Co shares in Q1 2026, an estimated $89K.
McAdam LLC first reported a position in Organon & Co in Q4 2025 and held it in 1 quarter.
McAdam LLC's Organon & Co position peaked at $89K in Q4 2025.
609 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on McAdam LLC's 13F filing for Q1 2026, filed 8 May 2026.